SERDs for primary breast cancer

Lancet Oncol. 2023 Sep;24(9):947-949. doi: 10.1016/S1470-2045(23)00291-7.

Authors

Masakazu Toi¹, Tomoyuki Aruga²

Affiliations

¹ Tokyo Metropolitan Cancer and Infectious Disease Centre, Komagome Hospital, Bunkyo-ku, Tokyo, 113-8677, Japan. Electronic address: [email protected].
² Tokyo Metropolitan Cancer and Infectious Disease Centre, Komagome Hospital, Bunkyo-ku, Tokyo, 113-8677, Japan.

PMID: 37657466
DOI: 10.1016/S1470-2045(23)00291-7

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms* / drug therapy
Female
Humans